Explore the world of thrombosis and hemostasis with "Clot Clot, Who's There?", a thought-provoking podcast brought to you by Vasculearn Network in collaboration with the Thrombosis and Haemostasis Editors (Thieme).
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
30%
Guest openness
Selective
Sign up to generate a grounded pitch for Clot, Clot, Who's There?.
Signup to Generate a PitchExplore the world of thrombosis and hemostasis with "Clot Clot, Who's There?", a thought-provoking podcast brought to you by Vasculearn Network in collaboration with the Thrombosis and Haemostasis Editors (Thieme).
Recent episodes include "Choosing Advanced PE Therapies: Evidence, Timing, and Technique From Risk Assessment to Treatment" (9 October 2026, 32 minutes), "Reading the Risk: PE Stratification in 2026 A New Era in PE Care" (9 October 2026, 33 minutes), and "Is Anticoagulation Still on Board? Rapid FXa Assessment" (1 August 2026, 29 minutes).
Clot, Clot, Who's There? publishes roughly monthly, with episodes averaging 27 minutes across 21 episodes.
Booking probability for Clot, Clot, Who's There? is 30%, and the host is rated Selective on guests. Clot, Clot, Who's There? requires a Pod Score of 80 or higher. Clot, Clot, Who's There?'s contact route on record: verified email.
The strongest fits for Clot, Clot, Who's There? are Health & Wellness Services and Doctors & Physicians. Clot, Clot, Who's There? has a health audience.
Clot, Clot, Who's There? is a health show with 21 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #21
More tools. New evidence. Tough decisions. With the 2026 AHA/ACC pulmonary embolism (PE) guidelines as a backdrop, when is anticoagulation enough, and when is it time to reach for advanced therapy? Behnood Bikdeli, Jane...
Episode #20
The blood pressure looks reassuring, but is it telling the whole story? In acute pulmonary embolism (PE), the next few hours can matter as much as the first set of vital signs. Behnood Bikdeli joins experts Jane...
Episode #18
Your patient is bleeding or needs urgent surgery, but no one knows when the last DOAC dose was taken. Is there still enough factor Xa inhibitor on board to change what happens next? Join experts Alex Spyropoulos...
Episode #17
Factor Xa inhibitors have transformed anticoagulation, but urgent bleeding or surgery may require decisions before clinicians know when the last dose was taken or how much anticoagulant activity remains. Join experts...
Episode #16
The COBRRA Trial and the Questions that Remain Clinicians have long relied on indirect comparisons when choosing between direct oral anticoagulants (DOACs) for VTE. The COBRRA trial changed that. Join experts Behnood...
Episode #15
<p >When a young, otherwise healthy patient presents with an upper extremity DVT, venous thoracic outlet syndrome should be high on the differential—but the diagnosis is often delayed or missed.</p> <p >Join experts...
Episode #14
<p >In urgent, high-stakes situations—like major bleeding or emergency surgery—how should clinicians assess coagulation in patients on factor Xa inhibitors? And more importantly, are we focusing on the right signal?</p>...
Episode #13
<p >Surviving a stroke is only the beginning. Preventing the next one is where the real clinical challenge lies—and for patients with non-cardioembolic stroke, the existing toolkit has long fallen short.</p> <p >Join...
Episode #12
<p >When it comes to antithrombotic therapy in coronary artery disease, the central question is no longer "What should everyone get?" It's "What's right for this patient?"</p> <p >In this episode, Drs. Heather Johnson...
Episode #11
<p >In this episode of Clot, Clot, Who's There? Drs. Christian Ruff (USA) and Giulio Francesco Romiti (Italy) chat about long-term anticoagulation management after successful atrial fibrillation ablation. They explore...
Episode #10
<p >In this episode of Clot Clot Who's There, Aviva Schwartz, Director of Education at Vasculearn Network, speaks with Professor Gregory Lip about key anticoagulation and atrial fibrillation data from 2025 and what lies...
Episode #9
<p >Host Dr. Alex Spyropoulos is joined by global experts Drs. James Douketis and Marc Samama for a focused, practical discussion on perioperative anticoagulation management in nonurgent procedures. Together, they...
Clot, Clot, Who's There?
<p >Host Tara Lech is joined by Drs. Scott Woller and Virginia Silvari for a thoughtful conversation on anticoagulation stewardship: what it is, why it matters, and how it can help patients who need antithrombotic...
Clot, Clot, Who's There?
<p >Join host Christian Weber, MD (LMU Munich) with vascular biology experts Kimberly Martinod, PhD (University of Rochester) and Konstantin Stark, MD (LMU Munich) as they explore the evolving science of...
Clot, Clot, Who's There?
<p >Join JoMarie Monzon, NP (Cedars-Sinai, Vasculearn Network) as she welcomes moderator Dr. Cassra Arbabi and guests Drs. Donald Baril (Cedars-Sinai) and Efthymios (Makis) Avgerinos (Athens Medical Center) for a...
Clot, Clot, Who's There?
<p>Dr. Bethany Samuelson Bannow is joined by Dr. Erik Klok and Dr. Geoff Barnes for a discussion on the best ways to communicate with your patients about anticoagulation. Anticoagulation therapy is a cornerstone of care...
Clot, Clot, Who's There?
<p >Join Dr. Jose Joglar, Chair of the 2023 U.S. AFib Guidelines, and Professor Gregory Lip, Chair of the ESC Council on Stroke, as they dive into the latest U.S. and European atrial fibrillation guidelines. From risk...
Episode #3
<p >Join host Dr. Kerstin de Wit as she welcomes Drs. Cecilia Becattini and Behnood Bikdeli to unpack one of the most nuanced challenges in thrombosis care: venous thromboembolism (VTE) risk stratification and...
Episode #2
<p > Does sex influence the risk of atrial fibrillation (AF)-related strokes? Is female sex truly an independent risk factor? And what common myths still cloud clinical understanding?</p> <p > In this episode, host Dr...
Episode #1
<p>In this inaugural episode of Clot Clot Who's There, global experts Professor Tatjana Potpara (Serbia), and Dr. Annabelle Volgman (USA) join moderator Dr. Panteleimon Papakonstantinou (Ireland) to discuss the rising...
Recent guests on Clot, Clot, Who's There?. Study who booked and why before you pitch.
PitchCentric classifies Clot, Clot, Who's There? under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ